ASX:VTI

Visioneering Technologies Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive VTI News and Ratings via Email

Sign-up to receive the latest news and ratings for Visioneering Technologies and its competitors with MarketBeat's FREE daily newsletter.


About Visioneering Technologies

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. It offers NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Visioneering Technologies (ASX:VTI) Frequently Asked Questions

What stocks does MarketBeat like better than Visioneering Technologies?

Wall Street analysts have given Visioneering Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Visioneering Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Visioneering Technologies' key executives?

Visioneering Technologies' management team includes the following people:
  • Dr. Stephen Snowdy, CEO & Exec. Director (Age 51, Pay $331.01k)
  • Mr. Brian D. Lane CPA, Chief Financial Officer (Age 59, Pay $223.87k)
  • Mr. Tony Sommer Jr., Sr. VP of Sales & Marketing
  • Dr. Richard A. Griffin, Founder & Medical Adviser
  • Ms. Leanne Ralph BBus, ACIS, AAICD, Company Sec.
  • Ms. Layna L. Mendlinger, Exec. Director of Marketing
  • Dr. Douglas P. Benoit OD, FAAO, Exec. Director of Professional Affairs

Who are some of Visioneering Technologies' key competitors?

Some companies that are related to Visioneering Technologies include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of VTI's competitors.

What is Visioneering Technologies' stock symbol?

Visioneering Technologies trades on the ASX under the ticker symbol "VTI."

How much money does Visioneering Technologies make?

Visioneering Technologies has a market capitalization of $0.00 and generates $6.18 million in revenue each year.

What is Visioneering Technologies' official website?

The official website for Visioneering Technologies is www.vtivision.com.

Where are Visioneering Technologies' headquarters?

Visioneering Technologies is headquartered at Po Box 2600,V26, Valley Forge, Pennsylvania 19482-2600.

How can I contact Visioneering Technologies?

Visioneering Technologies' mailing address is Po Box 2600,V26, Valley Forge, Pennsylvania 19482-2600. The company can be reached via phone at 844-884-5367.


This page was last updated on 9/17/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.